enVVeno Medical Corp (NVNO)
3.33
-0.08
(-2.35%)
USD |
NASDAQ |
Nov 15, 14:44
enVVeno Medical Cash from Investing (Quarterly): 6.22M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 6.22M |
June 30, 2024 | 3.974M |
March 31, 2024 | 2.197M |
December 31, 2023 | -22.14M |
September 30, 2023 | 4.445M |
June 30, 2023 | 7.004M |
March 31, 2023 | 2.827M |
December 31, 2022 | 5.516M |
September 30, 2022 | -1.692M |
June 30, 2022 | -38.31M |
March 31, 2022 | -0.069M |
December 31, 2021 | -0.065M |
September 30, 2021 | -0.152M |
June 30, 2021 | -0.127M |
March 31, 2021 | -0.024M |
December 31, 2020 | -0.0275M |
Date | Value |
---|---|
September 30, 2020 | -0.025M |
June 30, 2020 | -0.1225M |
March 31, 2020 | -0.0053M |
December 31, 2019 | -0.013M |
September 30, 2019 | -0.1719M |
June 30, 2019 | -0.1772M |
March 31, 2019 | -0.0018M |
December 31, 2018 | -0.0041M |
September 30, 2018 | -0.0083M |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.0691M |
September 30, 2017 | 0.1236M |
June 30, 2017 | -0.1156M |
March 31, 2017 | 0.0882M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-38.31M
Minimum
Jun 2022
7.004M
Maximum
Jun 2023
-1.530M
Average
-0.0245M
Median
Cash from Investing (Quarterly) Benchmarks
NeuroOne Medical Technologies Corp | -0.0148M |
SINTX Technologies Inc | 0.00 |
Nutriband Inc | -0.0389M |
Beyond Air Inc | 3.114M |
CVRx Inc | -0.037M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -4.276M |
Cash from Financing (Quarterly) | 13.59M |
Free Cash Flow | -16.74M |
Free Cash Flow Per Share (Quarterly) | -0.2667 |
Free Cash Flow Yield | -31.57% |